HAE Insider Trading Activity and SEC Form 4 Filings
HAE insider trading summary
Over the past 12 months, insiders at Haemonetics Corp (HAE) reported 1 open-market purchase worth $99K by 1 insider and no sales on SEC Form 4. Net insider buying was $99K.
Latest HAE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 10, 2025 | Mark W Kroll | Director | Buy | $99K (1,400 @ $70.56) |
| Jul 26, 2024 | Stewart W Strong | President, Global Hospital | Sell | $393K (4,312 @ $91.15) |
| Jul 12, 2024 | Anila Lingamneni | EVP, Chief Technology Officer | Sell | $7K (79 @ $90.00) |
| Jul 11, 2024 | Anila Lingamneni | EVP, Chief Technology Officer | Sell | $192K (2,136 @ $90.00) |
| May 29, 2024 | Stewart W Strong | President, Global Hospital | Sell | $775K (8,857 @ $87.53) |
| May 29, 2024 | Michelle L Basil | EVP and General Counsel | Sell | $363K (4,094 @ $88.57) |
| May 29, 2024 | Michelle L Basil | EVP and General Counsel | Sell | $782K (8,896 @ $87.86) |
| May 20, 2024 | Michelle L Basil | EVP and General Counsel | Sell | $153K (1,604 @ $95.08) |
| May 20, 2024 | Stewart W Strong | President, Global Hospital | Sell | $65K (686 @ $95.11) |
| May 20, 2024 | Josep Llorens | EVP, Global Manufacturing | Sell | $94K (987 @ $95.08) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.